Page last updated: 2024-10-30

metformin and Systolic Heart Failure

metformin has been researched along with Systolic Heart Failure in 3 studies

Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.

Research Excerpts

ExcerptRelevanceReference
"Metformin-treated patients had a higher body mass index, lower creatinine, and were less often on insulin."5.36Metformin therapy and outcomes in patients with advanced systolic heart failure and diabetes. ( Fonarow, GC; Horwich, TB; Shah, DD, 2010)
"Metformin-treated patients had a higher body mass index, lower creatinine, and were less often on insulin."1.36Metformin therapy and outcomes in patients with advanced systolic heart failure and diabetes. ( Fonarow, GC; Horwich, TB; Shah, DD, 2010)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Xu, X1
Lu, Z1
Fassett, J1
Zhang, P1
Hu, X1
Liu, X1
Kwak, D1
Li, J1
Zhu, G1
Tao, Y1
Hou, M1
Wang, H1
Guo, H1
Viollet, B1
McFalls, EO1
Bache, RJ1
Chen, Y1
Shah, DD1
Fonarow, GC1
Horwich, TB1
Giamouzis, G1
Triposkiadis, F1
Butler, J1

Other Studies

3 other studies available for metformin and Systolic Heart Failure

ArticleYear
Metformin protects against systolic overload-induced heart failure independent of AMP-activated protein kinase α2.
    Hypertension (Dallas, Tex. : 1979), 2014, Volume: 63, Issue:4

    Topics: AMP-Activated Protein Kinases; Animals; Aorta; Disease Models, Animal; Heart Failure, Systolic; Hype

2014
Metformin therapy and outcomes in patients with advanced systolic heart failure and diabetes.
    Journal of cardiac failure, 2010, Volume: 16, Issue:3

    Topics: Aged; Cohort Studies; Confidence Intervals; Diabetes Mellitus, Type 2; Female; Heart Failure, Systol

2010
Metformin use in patients with diabetes mellitus and heart failure: friend or foe?
    Journal of cardiac failure, 2010, Volume: 16, Issue:3

    Topics: Diabetes Mellitus, Type 2; Female; Heart Failure, Systolic; Humans; Hypoglycemic Agents; Male; Metfo

2010